The primary sources for this report include: Recalls (Enforcement Reports Database)+ The Food and Drug Administration (FDA) categorizes product recalls in its Enforcement Report database based on the level of health risk, labeling them as Class I, II, III, or "not yet classified." While the database includes drugs, food, cosmetics, medical devices, biologics, tobacco, and veterinary products, this report only covers selected drug recalls
Women taking glucagon-like peptide-1 (GLP-1) receptor agonists are not at increased risk of developing acne, according to a new study in the International Journal of Womens Dermatology
The best way to prevent vitamin E toxicity is to keep your daily intake of vitamin E both from supplements and foods below the UL of 1,000 mg per day
GLP-1 drugs help control blood sugar by stimulating the pancreas to release insulin and suppressing the release of another hormone
The molecule also supports the production of chemicals necessary for healthy cellular activity
A medication producing 24% weight loss means nothing if patients cannot tolerate it long enough to reach those results
